2017
Consent2Share: an integrated broad consenting process for re-contacting potential study subjects.
Journal of clinical and translational research
Research at a glance
Top areas of exploration
- Antiviral Agents , 58 publications
- Hepatitis C, Chronic , 52 publications
- Drug Therapy, Combination , 34 publications
- Hepatitis C , 31 publications
Research activity
My publications
Filter publications
236 publications
2017
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.
Gut
•2017
Evaluating the Efficacy of a Registry linked to a Consent to Re-Contact Program and Communication Strategies for Recruiting and Enrolling Participants into Clinical Trials.
Contemporary clinical trials communications
•2017
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.
The New England journal of medicine
•2017
Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial.
The Lancet. Infectious diseases
•